Endocrine Abstracts

Conflicting results of estimated average glucose (eAG) calculated from HbA1c and average glucose values (AG) derived from continuous glucose monitoring (CGM) are a very frequent source of confusion and frustrations in the dialogue with patients. Recently the term glucose management indicator (GMI) has been coined to describe HbA1c estimated from AG. The aim of this presentation is to elucidate the relation between calculated and estimated HbA1c and average glucose values on th...

Background: Vitamin D deficiency has been proposed to play a role in development and course of Graves’ disease (GD). Muscle weakness and fatigue are shared features of GD and vitamin D deficiency. We aimed to investigate whether vitamin D supplementation would improve restoration of muscle performance and thyroid-related quality of life (QoL) in GD.Methods: In a double-blinded clinical trial, hyperthyroid patients with a first time diagnosis of GD w...

Background: Risk of cardiovascular disease (CVD) and mortality is increased in Graves’ disease (GD) even years after initial diagnosis and treatment. The mechanisms are incompletely understood. Vitamin D insufficiency is associated with an increased risk of CVD and has been reported to occur frequently in GD. Pulse wave velocity (PWV) and blood pressure (BP) are important predictors of CVD. We performed a clinical trial, testing whether vitamin D supplementation affects P...